Real-time PCR-assay in the delivery suite for determination of group B streptococcal colonization in a setting with risk-based antibiotic prophylaxis

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 27, Issue 4, 2014, Pages 328-332

  Håkansson, Stellan ^a   Källén, Karin ^b   Bullarbo, Maria ^c   Holmgren, Per Åke ^a   Bremme, Katarina ^d,e   Larsson, Åsa ^a   Norman, Margareta ^f   Norén, Håkan ^g   Ortmark Wrede, Catharina ^h   Pettersson, Karin ^e   Saltvedt, Sissel ^h   Sondell, Birgitta ^a   Tokarska, Magdalena ^d   Von Vultee, Anna ^e   Jacobsson, Bo ^g,i  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF LUND   (Sweden)

^c Section of Rheumatology   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

^f DANDERYD HOSPITAL   (Sweden)

^g SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^h STOCKHOLM SÖDER HOSPITAL   (Sweden)

ⁱ NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Antibiotics; Delivery; Prophylaxis; Real time PCR; S. agalactiae

Indexed keywords

PENICILLIN G; BACTERIAL DNA;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIURIA; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; INTRAPARTUM CARE; MULTICENTER STUDY; POLYMERASE CHAIN REACTION SYSTEM; PREDICTIVE VALUE; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STREPTOCOCCUS AGALACTIAE; VAGINA SMEAR; CLINICAL TRIAL; GENETICS; ISOLATION AND PURIFICATION; NEWBORN; PERINATAL CARE; PREGNANCY; PREVENTION AND CONTROL; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; STREPTOCOCCAL INFECTIONS; TRANSMISSION; VERTICAL TRANSMISSION;

ANTIBIOTIC PROPHYLAXIS; DNA, BACTERIAL; FEMALE; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PERINATAL CARE; PREGNANCY; REAL-TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 84892760774     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2013.818128     Document Type: Article

References (26)

1. Van Dyke MK, Phares CR, Lynfield R, et al. Evaluation of universal antenatal screening for group B Streptococcus. N Eng J Med 2009;360:2626-36.
2. Stoll BJ, Hansen NI, Sánchez PJ, et al. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics 2011;127:817-26.
3. Verani JR, McGee L, Schrag SJ. Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010. MMWR Recomm Rep 2010;59:1-36.
4. Benitz WE, Gould JB, Druzin ML. Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Pediatrics 1999;103:e77.
5. Lin FY, Brenner RA, Johnson YR, et al. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease. Am J Obstet Gynecol 2001;184:1204-10.
6. Håkansson S, Axemo P, Bremme K, et al. Group B streptococcal carriage in Sweden: a national study on risk factors for mother and infant colonisation. Acta Obstet Gynecol Scand 2007;87:50-8.
7. Håkansson S, Källén K. Impact and risk factors for early-onset group B streptococcal morbidity: analysis of a national, populationbased cohort in Sweden 1997-2001. BJOG 2006;113:1452-8.
8. National Board of Health and Welfare. Prevention of early onset group B streptococcal in fections in the new born (In Swedish), 2008. Cited March 31 2013. Available from http://www.socialstyrelsen.se/Lists/Artikelkatalog/ Attachments/8836/2008-130-7-20081307.pdf [Last accessed 15 Jul 2013].
9. Keski-Nisula L, Kyynäräinen HR, Kärkäinen U, et al. Maternal intrapartum antibiotics and decreased vertical transmission of Lactobacillus to neonates during birth. Acta Paediatr 2013;102: 480-5.
10. Bedford Russell AR, Murch SH. Could peripartum antibiotics have delayed health consequences for the infant? BJOG 2006;113: 758-65.
11. Conroy ME, Shi HN, Walker WA. The long-term health effects of neonatal microbial flora. Curr Opin Allergy Clin Immunol 2009; 9:197-201.
12. El Helali N, Nguyen JC, Ly A, et al. Diagnostic accuracy of a rapid real-time polymerase chain reaction assay for universal intrapartum group B streptococcal screening. Clin Infect Dis 2009; 49:417-23.
13. Towers CV, Rumney PJ, Asrat T, et al. The accuracy of late third-trimester antenatal screening for group B Streptococcus. Am J Perinatol 2010;27:785-90.
14. Lin FY, Weisman LE, Azimi P, et al. Assessment of intrapartum antibiotic prophylaxis for the prevention of early onset group B streptococcal disease. Pediatr Infect Dis J 2011;30: 759-63.
15. Gavino M, Wang E. A comparison of a new rapid real-time polymerase chain reaction system to traditional culture in determining group B streptococcus colonization. Am J Obstet Gynecol 2007;197:388.e1-4.
16. Granlund M, Axemo P, Bremme K, et al; Swedish Working Group for the Prevention of Perinatal Group B Streptococcal Infections. Antimicrobial resistance in colonizing group B Streptococci before the implementation of a Swedish intrapartum antibiotic prophylaxis program. Eur J Clin Microbiol Infect Dis 2010;29:1195-201.
17. Heath PT, Schuchat A. Perinatal group B streptococcal disease. Best Pract Res Clin Obstet Gynaecol 2007;21:411-24.
18. Dillon HC, Gray E, Pass MA, Gray BM. Anorectal and vaginal carriage of group B streptococci during pregnancy. J Infect Dis 1982;145:794-9.
19. Regan JA, Klebanoff MA, Nugent RP. The epidemiology of group B streptococcal colonization in preganancy: Vaginal infections and prematurity study goup. Obstet Gynecol 1991;77:604-10.
20. Ohlsson A, Shah VS. Intrapartum antibiotics for known maternal Group B streptococcal colonization. Cochrane Database Syst Rev 2009;3:CD007467.
21. Gray JW, Milner PJ, Edwards EH, et al. Feasibility of using microbiology diagnostic tests of moderate or high complexity at the point-of-care in a delivery suite. J Obstet Gynaecol 2012;32: 458-60.
22. Young BC, Dodge LE, Gupta M, et al. Evaluation of a rapid, real-time intrapartum group B streptococcus assay. Am J Obstet Gynecol 2011;205:372.e1-6.
23. El Helali N, Giovangrandi Y, Guyot K, et al. Cost and effectiveness of intrapartum group B streptococcus polymerase chain reaction screening for term deliveries. Obstet Gynecol 2012;119:822-9.
24. Lin FY, Brenner RA, Johnson YR, et al. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease. Am J Obstet Gynecol 2001;184:1204-10.
25. Vergnano S, Embleton N, Collinson A, et al. Missed opportunities for preventing group B Streptococcus infection. Arch Dis Child Fetal Neonatal Ed 2010;95:F72-3.
26. Puopolo KM, Draper D, Wi S, et al. Estimating the probability of neonatal early-onset infection on the basis of maternal risk factors. Pediatrics 2011;128:e1155-63.